Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-05-11 | ||||||
| REV | |||||||
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.090 | -0.110 | -0.0200 | ||||
| REV | 2.840M | 3.024M | 184.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CRIS | Curis | 1.45% | 962.8M |
Curis Company Questions & Answers
Q
How do I buy Curis (CRIS) stock?
A
You can purchase shares of Curis (NASDAQ: CRIS) through any online brokerage.
Q
Who are Curis's (CRIS) main competitors?
A
There are no as such competitors for Curis.
Q
What is the target price for Curis?
A
The latest price target for Curis (NASDAQ: CRIS) was reported by B. Riley FBR on 2021-03-25. The analyst firm set a price target for 19.00 expecting CRIS to rise to within 12 months (a possible 80.61% upside). 5 analyst firms have reported ratings in the last year.
Q
How much is Curis (CRIS) stock ?
A
The stock price for Curis (NASDAQ: CRIS) is $10.52 last updated Thu Apr 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
Q
When is the next Curis (CRIS) dividend?
A
There are no upcoming dividends for Curis.
Q
When is Curis (NASDAQ:CRIS) reporting earnings?
A
Curis’s Q1 earnings are confirmed from now on May 11, 2021.
Q
When is the upcoming split for CRIS?
A
There is no upcoming split for Curis.